Home > Result Summaries: Compounds > fosamprenavir > Result Summary for APV10013

Result Summary for APV10013

Result Summary

Protocol ID:	APV10013
Clinical Study ID:	APV10013
Official Title:	A Phase I, Randomized, Open Label, Three Period, Single Sequence, Steady State, Drug-Drug Interaction Study between Atorvastatin 10mg QD and GW433908 1400mg BID and between Atorvastatin 10mg QD and GW433908 700mg BID + Ritonavir 100mg BID in Healthy Adult Subjects
Phase:	Phase 1
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus
Generic Name:	fosamprenavir
Trade/Product Name:	lexiva;lexiva
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	MB Wire, KL Baker, Y Lou, S Weller, DS Stein. Comparison of GW433908 (908) Single and Steady State Pharmacokinetics (PK): Induction potential and AAG changes (APV10013). 43rd ICAAC, 2003. A-1607 MB Wire, KL Baker, KHP Moore, S Weller, Y Lou, DS Stein. The Pharmacokinetic (PK) Interaction of GW433908 (908) with Atorvastatin (ATO) and 908/ Ritonavir (RTV) with ATO (APV10013). 43rd ICAAC, 2003. A-1622